Briacell Therapeutics Corp. (BCTXF) - OTCQB
There are currently no headlines for this stock.
Company Description
BriaCell is a breast cancer immunotherapy biotech which has developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. Thevaccine has demonstrated highly encouraging Phase-I safety and efficacy data in patients with advanced breast cancers.
Industry: Steel & Iron
Country: United States